A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB (RWS-MTB)
A Real-world Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on Molecular Profiling and Multidisciplinary Team Consultation
Sponsor: Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Listed as NCT06781151, this observational or N/A phase trial focuses on Cervical Cancer Recurrent and Endometrial Cancer Recurrent and remains actively recruiting participants. Sponsored by Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center, it has been updated 2 times since 2024, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
2 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Feb 2025 — Sep 2025 [monthly]
Recruiting
First recorded
Apr 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
- Obstetrics & Gynecology Hospital of Fudan University
- Sun Yat-sen University
For direct contact, visit the study record on ClinicalTrials.gov .